Creating a National Infrastructure for Good Clinical Practice in Clinical Trials in Ukraine

被引:0
|
作者
Yurii I. Kundiiev
Peter N. Vitte
Vyctor G. Lyzogub
Alla Stepanenko
机构
[1] National Bioethics Committee of Ukraine,Clinical Trials Coordination and Control Board, State Pharmacological Center
[2] Information Centre on Bioethics,Institute for Occupational Health
[3] Ministry of Health,undefined
[4] Academy of Medical Sciences of Ukraine,undefined
关键词
Ethical Review; Good Clinical Practice; Medical Institution; Pharmaceutical Product; Bioethic Committee;
D O I
10.1007/BF03256732
中图分类号
学科分类号
摘要
This article examines the current Ukrainian approach to creating a national infrastructure for medicines advancement and human subjects protection through clinical trials based on good clinical practice (GCP). It explores the roles of the government, the healthcare society, ethics committees and industry in contributing to the development of a national infrastructure that contributes to national needs in health research as well as the global development of medicines.
引用
收藏
页码:355 / 358
页数:3
相关论文
共 50 条
  • [1] Is good clinical research practice for clinical trials good clinical practice?
    Yastrubetskaya, O
    Chiu, E
    OConnell, S
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1997, 12 (02) : 227 - 231
  • [2] Clinical Trials and Good Clinical Practice
    Suzuki-Nishimura, Tamiko
    JOURNAL OF HEALTH SCIENCE, 2010, 56 (03) : 231 - 238
  • [3] MRC guidelines for good clinical practice in clinical trials
    Vere, D
    JOURNAL OF MEDICAL ETHICS, 1999, 25 (03) : 280 - 281
  • [4] Clinical trials: Towards good practice
    Ablett, S
    ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (03) : 283 - 285
  • [5] CLINICAL-TRIALS AND CLINICAL ETHIC - GOOD CLINICAL-PRACTICE
    GRACIA, D
    MEDICINA CLINICA, 1993, 100 (09): : 333 - 336
  • [6] Good clinical practice in clinical trials: training of clinicians, incitation to apply good clinical practice and assessment of compliance
    Belorgey, C
    Demarez, JP
    Jaillon, P
    THERAPIE, 2002, 57 (04): : 339 - 346
  • [7] Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines
    den Heijer, Jonas M.
    Heuberger, Jules A. A. C.
    Hijma, Hemme
    Kruithof, Annelieke C.
    van Smeden, Jeroen
    Groeneveld, Geert Jan
    Burggraaf, Jacobus
    Cohen, Adam
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4552 - 4559
  • [8] GOOD CLINICAL PRACTICE FOR PHASE I CLINICAL TRIALS UNITS
    Pena-Pardo, M. A.
    Moreu-Martin, R.
    Pol-Viedma, M. V.
    Sentamans-Gomez, A.
    Zapater-Hernandez, P.
    Esteban-Blanes, P.
    Peiro-Peiro, A. M.
    Horga de la Parte, J. F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 52 - 52
  • [9] Current Status of Clinical Trials and Good Clinical Practice in Japan
    Tominaga T.
    Drug information journal : DIJ / Drug Information Association, 1997, 31 (4): : 1071 - 1078
  • [10] Good Publication Practice guidelines for clinical trials?
    Alfaro, V
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (01) : 97 - 98